Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)
FDA Device Recall #Z-0238-2022 — Class II — September 24, 2021
Recall Summary
| Recall Number | Z-0238-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 24, 2021 |
| Status | Ongoing |
| Voluntary | FDA Mandated |
Recalling Firm
| Firm | Philips Healthcare |
| Location | Andover, MA |
| Product Type | Devices |
| Quantity | 226 units |
Product Description
Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)
Reason for Recall
3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray equipment with the capability of 3D X-ray imaging. Before starting a 3D-RA scan, the detector of the Philips Azurion system must be positioned in portrait or landscape orientation with an angle of 0 or +/-90 degrees relative to the 3D scan direction. Philips has discovered that Azurion releases 2.1(L1) and 2.1(L2) allow creation of a 3D-RA scan with a deviating detector orientation of up to 3 degrees from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees), relative to the 3D scan direction. 3D-RA scans with a deviating detector orientation of ore than 1.0 degree from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees) cannot be reconstructed with the 3D-RA reconstruction software.
Distribution Pattern
US Nationwide distribution
Lot / Code Information
Azurion 2.1(L1) and 2.1(L2)
Other Recalls from Philips Healthcare
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2520-2023 | Class II | Incisive CT, software version 5.0 | Aug 2, 2023 |
| Z-0737-2022 | Class II | Philips StentBoost Live R2.0 application, when ... | Feb 2, 2022 |
| Z-0241-2022 | Class II | CombiDiagnost R90 is multi-functional general R... | Sep 22, 2021 |
| Z-0239-2022 | Class II | DigitalDiagnost C90 | Sep 22, 2021 |
| Z-0240-2022 | Class II | ProxiDiagnost N90 is multi-functional general R... | Sep 22, 2021 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.